SHANGHAI - Chinese drugmaker Sinovac Biotech has begun to administer a coronavirus vaccine to thousands of its staff as the race to secure an immunization for COVID-19 enters advanced clinical trials.
Nasdaq-listed Sinovac Biotech hopes to get production license this year
SHANGHAI - Chinese drugmaker Sinovac Biotech has begun to administer a coronavirus vaccine to thousands of its staff as the race to secure an immunization for COVID-19 enters advanced clinical trials.